Table of Contents
- Product Overview & Specifications
- Key Applications & Industrial Uses
- Implementation Case Studies
- Verified Client Success Stories
- Contact for Technical Consultation
(R)-5-Hydroxymethyldihydrofuran-2-one CAS 52813-63-5: Technical Specifications
Molecular Characteristics
| Parameter | Specification | Comparison with S-Isomer |
|---|---|---|
| CAS Number | 52813-63-5 | Enantiomeric pair differentiation |
| Molecular Formula | C₅H₈O₃ | Identical molecular composition |
| Molecular Weight | 116.12 g/mol | Same molecular weight |
| Optical Rotation | [α]D²⁰ +38° (c=1, H₂O) | Mirror-image rotation values |
Quality Specifications
| Purity Grade | Standard | Pharma Grade | Research Grade |
|---|---|---|---|
| Chemical Purity | >98% | >99.5% | >97% |
| Enantiomeric Excess | 98% ee | 99.9% ee | 95% ee |
Industrial Applications & Functional Uses
Pharmaceutical Intermediate
Primary use in synthesizing chiral β-lactam antibiotics and antiviral agents. Critical for constructing carbocyclic nucleoside analogs with specific stereochemistry.
Asymmetric Synthesis
Essential chiral building block for:
– Prostaglandin derivatives
– Statin side chain construction
– Taxol precursor development
Functional Materials
Key component in:
– Liquid crystal precursors
– Biodegradable polymer initiators
– Chiral stationary phases for HPLC
Implementation Case Studies
Case 1: Antiviral API Development
Application: Nucleoside reverse transcriptase inhibitor synthesis
Result: Achieved 92% yield in key cyclization step with 99.3% ee
Process Benefit: Reduced purification steps by 40% compared to racemic routes
Case 2: Specialty Polymer Production
Application: Biodegradable shape-memory polyurethane synthesis
Result: Enhanced thermal transition properties (Tg = 58°C vs 42°C in racemic form)
Material Advantage: Improved degradation rate control in physiological conditions
Verified Client Implementations
Pharmaceutical Manufacturer: ABC Therapeutics
Project: HCV Protease Inhibitor Development
Usage: 15kg in Phase III clinical trial material production
Outcome: Successfully scaled to 200L batch process with 89% yield
Client Feedback: “Consistent enantiopurity crucial for our NDA submission”
Biotech Company: XenoBiologics
Application: Chiral catalyst development for aminohydroxylation
Consumption: 8.2kg in catalyst optimization study
Result: Achieved 19:1 diastereomeric ratio improvement
Testimonial: “Reliable chirality control enabled precise reaction engineering”
Technical Consultation & Ordering
Contact Our Experts
For batch-specific COA or custom synthesis requirements:
Email: info@vivalr.com
Phone: (86) 15866781826
Request Product Documentation
Available upon request:
– Detailed stability studies (ICH guidelines)
– Regulatory support packages
– Custom chiral purity specifications



评论
目前还没有评论。